Fonte: Canadian Journal of Physiology and Pharmacology. Unidade: FMRP
Assuntos: TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, ALDOSTERONA, DOENÇAS CARDIOVASCULARES, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLATUNJI, Lawrence A. et al. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats. Canadian Journal of Physiology and Pharmacology, v. 97, n. 1, p. 65-74, 2019Tradução . . Disponível em: https://doi.org/10.1139/cjpp-2018-0416. Acesso em: 06 ago. 2024.APA
Olatunji, L. A., Adeyanju, O. A., Michael, O. S., Usman, T. O., Tostes, R. de C. A., & Soladoye, A. O. (2019). Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats. Canadian Journal of Physiology and Pharmacology, 97( 1), 65-74. doi:10.1139/cjpp-2018-0416NLM
Olatunji LA, Adeyanju OA, Michael OS, Usman TO, Tostes R de CA, Soladoye AO. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats [Internet]. Canadian Journal of Physiology and Pharmacology. 2019 ; 97( 1): 65-74.[citado 2024 ago. 06 ] Available from: https://doi.org/10.1139/cjpp-2018-0416Vancouver
Olatunji LA, Adeyanju OA, Michael OS, Usman TO, Tostes R de CA, Soladoye AO. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats [Internet]. Canadian Journal of Physiology and Pharmacology. 2019 ; 97( 1): 65-74.[citado 2024 ago. 06 ] Available from: https://doi.org/10.1139/cjpp-2018-0416
